Pär-Ola Bendahl
51 – 60 of 234
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
- Contribution to journal › Article
-
Mark
Pre-operative plasma cell-free circulating tumor DNA and serum protein tumor markers as predictors of lung adenocarcinoma recurrence
Isaksson, Sofi LU ; George, Anthony M. LU ; Jönsson, Mats LU ; Cirenajwis, Helena LU ; Jönsson, Per ; Bendahl, Pär Ola LU ; Brunnström, Hans LU
; Staaf, Johan
LU
; Saal, Lao H.
LU
and Planck, Maria
LU
(2019)
In Acta Oncologica
58(8).
p.1079-1086
- Contribution to journal › Article
- 2018
-
Mark
Assessment of early response biomarkers in relation to long-term survival in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab : Results from the Phase II PROMIX trial
Kimbung, Siker LU ; Markholm, Ida ; Bjöhle, Judith ; Lekberg, Tobias ; Wachenfeldt, von Anna ; Azavedo, Edward ; Saracco, Ariel ; Hellström, Mats ; Veerla, Srinivas LU
and Paquet, Eric
, et al.
(2018)
In International Journal of Cancer
142(3).
p.618-628
- Contribution to journal › Article
-
Mark
Stability of oestrogen and progesterone receptor antigenicity in formalin‐fixed paraffin‐embedded breast cancer tissue over time
Ehinger, Anna LU
; Bendahl, Pär-Ola
LU
; Rydén, Lisa
LU
; Fernö, Mårten
LU
and Alkner, Sara
LU
(2018)
In APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
126(9).
p.746-754
- Contribution to journal › Article
-
Mark
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer : A sub-study of RASTEN - A randomized trial with low molecular weight heparin
- Contribution to journal › Article
-
Mark
Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer
Forsare, Carina LU
; Bak, Martin
; Falck, Anna Karin
LU
; Grabau, Dorthe
LU
; Killander, Fredrika
LU
; Malmström, Per
LU
; Rydén, Lisa
LU
; Stål, Olle
; Sundqvist, Marie
and Bendahl, Pär Ola
LU
, et al.
(2018)
In BMC Cancer
18(1).
- Contribution to journal › Article
-
Mark
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
Hagman, Helga LU
; Bendahl, Pär Ola
LU
; Lidfeldt, Jon
LU
; Belting, Mattias
LU
and Johnsson, Anders
LU
(2018)
In PLoS ONE
13(12).
- Contribution to journal › Article
-
Mark
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
- Contribution to journal › Article
-
Mark
Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study
Brueffer, Christian LU
; Vallon-Christersson, Johan
LU
; Grabau, Dorthe
LU
; Ehinger, Anna
LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
; Malina, Janne
; Chen, Yilun
LU
; Bendahl, Pär-Ola
LU
and Manjer, Jonas
LU
, et al.
(2018)
San Antonio Breast Cancer Symposium, 2017
In Cancer research. Supplement
78(4).
- Contribution to journal › Published meeting abstract
-
Mark
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
Brueffer, Christian LU
; Vallon-Christersson, Johan
LU
; Grabau, Dorthe
LU
; Ehinger, Anna
LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
; Malina, Janne
; Chen, Yilun
LU
; Bendahl, Pär-Ola
LU
and Manjer, Jonas
LU
, et al.
(2018)
In JCO Precision Oncology
2.
p.1-18
- Contribution to journal › Article